To open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated ...
The summit brought together global leaders to reframe advocacy as the engine of patient-centred change, proving that connected voices can drive collective impact ...
The rebranding of Uniphar’s US divisions aims to strengthen its integrated platform across the product life cycle ...
Could it be,” he asked, “that creativity needs slack and while some companies have allowed for this, others haven’t, and this is reflected in the creativity of their customer experience approaches?” I ...
Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...
Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...
Novartis has reported new results from two ongoing phase 3 trials evaluating ianalumab in patients with Sjögren’s disease, ...
Metro maps in unfamiliar cities offer a complex, often – confusing, matrix of opportunities with their twisting lines, but ...
The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...
UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...
Medherant, a clinical-stage company developing treatments using a novel transdermal drug delivery technology, has reported ...
Medicus Pharma, a biotech and life sciences company developing novel and disruptive therapeutics, has announced the enrolment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results